Literature DB >> 14736928

Tanapox infection in a college student.

A Damian Dhar1, Andrew E Werchniak, Yu Li, Jeoffry B Brennick, Cynthia S Goldsmith, Richard Kline, Inger Damon, Sidney N Klaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14736928     DOI： 10.1056/NEJMoa031467

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  GC content-based pan-pox universal PCR assays for poxvirus detection.

Authors:  Yu Li; Hermann Meyer; Hui Zhao; Inger K Damon
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

3.  The poxvirus A35 protein is an immunoregulator.

Authors:  Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Orthopox Viruses: Infections in Humans.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

5.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

6.  Human infection with a zoonotic orthopoxvirus in the country of Georgia.

Authors:  Neil M Vora; Yu Li; Marika Geleishvili; Ginny L Emerson; Ekaterine Khmaladze; Giorgi Maghlakelidze; Archil Navdarashvili; Khatuna Zakhashvili; Maka Kokhreidze; Marina Endeladze; Gela Mokverashvili; P S Satheshkumar; Nadia Gallardo-Romero; Cynthia S Goldsmith; Maureen G Metcalfe; Inger Damon; Edmond F Maes; Mary G Reynolds; Juliette Morgan; Darin S Carroll
Journal:  N Engl J Med       Date:  2015-03-26       Impact factor: 91.245

7.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

8.  Clinical experience, infection control practices and diagnostic algorithms for poxvirus infections - an Emerging Infections Network survey.

Authors:  Christine M Hughes; Edith R Lederman; Mary G Reynolds; Inger K Damon; R Ryan Lash; Susan E Beekmann; Philip M Polgreen
Journal:  BMC Res Notes       Date:  2010-02-25

9.  Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Mark D Mannie; Rachel L Roper
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 10.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.